ConductScience.org, home
Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma
API referenceFor AI assistants

Trial · NCT01245673

Participant flow19

How many started, completed or left each group, period by period.

1 to 19 of 19

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
EnrollmentSTARTEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,28
EnrollmentCOMPLETEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,27
EnrollmentNOT COMPLETEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,1
Pre Transplant VaccinationsSTARTEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,27
Pre Transplant VaccinationsPre Transplant Vaccinations 1-3MAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,27
Pre Transplant VaccinationsCOMPLETEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,27
Pre Transplant VaccinationsNOT COMPLETEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,0
Activated/Costimulated Autologous T CellSTARTEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,27
Activated/Costimulated Autologous T CellCOMPLETEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,27
Activated/Costimulated Autologous T CellNOT COMPLETEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,0
MAGE-A3, Hiltonol®, PVC After T CellsSTARTEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,27
MAGE-A3, Hiltonol®, PVC After T CellsCOMPLETEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,26
MAGE-A3, Hiltonol®, PVC After T CellsNOT COMPLETEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,1
Start LenalidomideSTARTEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,26
Start LenalidomideCOMPLETEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,26
Start LenalidomideNOT COMPLETEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,0
Maintenance: MAGE-A3, PVC After T CellsSTARTEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,26
Maintenance: MAGE-A3, PVC After T CellsCOMPLETEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,26
Maintenance: MAGE-A3, PVC After T CellsNOT COMPLETEDMAGE A-3, GM-CSF, Hiltonol®, T Cells, Lenalidomide,0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01245673/flow

API referenceFor AI assistants